NCT00200512
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Walton Centre for Neurology and Neurosurgery Liverpool, United Kingdom
- The Morriston Hospital Swansea, United Kingdom
Clinical trial condition
Synucleinopathies
Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.
3,537 public trials
648 recruiting studies
Synucleinopathies trial results
NCT00230997
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +9 more
- Locations
-
- Indiana University for AD and Related Disorders Indianapolis, Indiana, United States
- Buffalo Insititute for Medical Research Buffalo, New York, United States
- Alzheimer's Center of Pittsburgh Pittsburgh, Pennsylvania, United States
- UTHSCSA Psychiatry Department San Antonio, Texas, United States
NCT00087542
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
- Locations
-
- Fountain Valley, California, United States
- Sunnyvale, California, United States
- Danbury, Connecticut, United States
- Pompano Beach, Florida, United States
NCT00004451
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- University of Virginia Charlottesville, Virginia, United States
NCT00103597
- Conditions
- Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +16 more
- Locations
-
- Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia
NCT00145171
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
Not specified
NCT00142545
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Mylan Pharmaceuticals Morgantown, West Virginia, United States
NCT00006488
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Department of Neurology New York, United States
Completed
Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease
NCT00004387
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
Not specified
NCT00004670
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
Not specified